Garofalo Health Care S.p.A. (BIT:GHC)
5.60
+0.10 (1.82%)
Last updated: Jul 28, 2026, 10:16 AM CET
Garofalo Health Care Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 495 | 494 | 483 | 411 | 327 | 491 | |
Market Cap Growth | 9.42% | 2.23% | 17.56% | 25.59% | -33.34% | 13.47% |
Enterprise Value | 724.56 | 700.59 | 692.8 | 618.62 | 472.26 | 633.43 |
Last Close Price | 5.60 | 5.59 | 5.46 | 4.64 | 3.68 | 5.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.77 | 21.50 | 22.75 | 25.78 | 15.33 | 26.19 |
Forward PE | 19.53 | 17.52 | 18.18 | 16.28 | 13.12 | 20.37 |
PEG Ratio | - | 1.28 | 1.28 | 1.28 | 1.28 | 1.85 |
PS Ratio | 1.01 | 1.01 | 1.03 | 1.11 | 1.01 | 1.73 |
PB Ratio | 1.38 | 1.46 | 1.50 | 1.37 | 1.17 | 1.88 |
P/FCF Ratio | 14.07 | 27.24 | 28.92 | 11.89 | 10.89 | 37.42 |
P/OCF Ratio | 7.64 | 10.07 | 13.80 | 8.22 | 7.46 | 13.52 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.48 | 1.44 | 1.47 | 1.68 | 1.46 | 2.23 |
EV/EBITDA Ratio | 10.21 | 9.59 | 9.97 | 10.20 | 9.44 | 14.48 |
EV/EBIT Ratio | 17.04 | 15.52 | 15.70 | 15.77 | 14.91 | 22.44 |
EV/FCF Ratio | 20.61 | 38.66 | 41.48 | 17.89 | 15.72 | 48.30 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.66 | 0.65 | 0.69 | 0.76 | 0.63 | 0.70 |
Debt / EBITDA Ratio | 3.32 | 3.10 | 3.33 | 3.77 | 3.53 | 4.20 |
Debt / FCF Ratio | 6.70 | 12.49 | 13.84 | 6.62 | 5.88 | 14.01 |
Net Debt / Equity Ratio | 0.60 | 0.58 | 0.62 | 0.69 | 0.52 | 0.55 |
Net Debt / EBITDA Ratio | 2.93 | 2.68 | 2.87 | 3.39 | 2.90 | 3.25 |
Net Debt / FCF Ratio | 5.92 | 10.81 | 11.92 | 5.95 | 4.83 | 10.86 |
Asset Turnover | 0.56 | 0.57 | 0.57 | 0.51 | 0.51 | 0.52 |
Inventory Turnover | 66.15 | 66.37 | 67.62 | 61.83 | 62.35 | 60.62 |
Quick Ratio | 1.11 | 1.18 | 1.09 | 0.68 | 0.89 | 0.96 |
Current Ratio | 1.15 | 1.23 | 1.14 | 0.71 | 0.92 | 1.00 |
Return on Equity (ROE) | 6.16% | 6.90% | 6.89% | 7.20% | 7.94% | 8.12% |
Return on Assets (ROA) | 1.93% | 3.66% | 3.82% | 3.93% | 3.90% | 4.08% |
Return on Invested Capital (ROIC) | 3.05% | 5.81% | 6.05% | 6.08% | 6.00% | 6.30% |
Return on Capital Employed (ROCE) | 5.80% | 6.32% | 6.80% | 7.09% | 6.26% | 6.56% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.39% | 4.65% | 4.40% | 3.88% | 6.52% | 3.82% |
FCF Yield | 7.11% | 3.67% | 3.46% | 8.41% | 9.18% | 2.67% |
Dividend Yield | 1.66% | 1.53% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 34.94% | 32.42% | 0.00% | 0.00% | 0.00% | 0.00% |
Buyback Yield / Dilution | - | -0.14% | 0.10% | 0.40% | 0.37% | -9.34% |
Total Shareholder Return | 1.66% | 1.39% | 0.10% | 0.40% | 0.37% | -9.34% |